Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.

Date publication

juin 2023

Journal

Journal of translational medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Dr FAVIER Laure

Tous les auteurs :
Nigon E, Lefeuvre-Plesse C, Martinez A, Chauleur C, Lortholary A, Favier L, Bats AS, Guille A, AdélaÏde J, Finetti P, de Casteljac V, Provansal M, Mamessier E, Bertucci F, Ray-Coquard I, Sabatier R

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37353806

Résumé

Uterine clear cell carcinomas (CCC) represent less than 5% of uterine cancers. Their biological characteristics and clinical management remain uncertain. A multicenter study to explore both clinical and molecular features of these rare tumors was conducted.

Mots clés

Clear cell carcinoma, Gene expression profiling, Genomics, Tissue micro-array, Uterine cancer

Référence

J Transl Med. 2023 06 23;21(1):408